SCHEMBL3394362

SCHEMBL3394362

Cc1cnc(N(C)c2cc(-c3ccccc3)[nH]n2)nc1-c1ccccc1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
GABRG2 P18507 5/20 0.37
GABRB3 P28472 5/20 0.37
GABRA1 P14867 4/20 0.37
GABRA2 P47869 4/20 0.37
TRPA1 O75762 1/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GABRA5 P31644 3/20 0.34
GABRA3 P34903 3/20 0.34
DYRK1A Q13627 2/20 0.34
CDK1 P06493 2/20 0.34
KDR P35968 2/20 0.34
PLK4 O00444 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3395407 0.86 KCNH2 (0.40) CYP1A2GSK3AGSK3BHSD17B10
SCHEMBL3434435 0.84 KCNH2 (0.33) GABRG2GABRB3CYP1A2GABRA5GABRA3
SCHEMBL3394361 0.76 KDR (0.41) PTGESKDM4EMAPTMAPK1KMT2A
SCHEMBL13425741 0.69 KDR (0.37) KDM4EMAPK1CYP1A2CDK1KDR
SCHEMBL3433177 0.67 KCNH2 (0.36) PIM1GSK3AGSK3B
SCHEMBL3363995 0.67 ADORA1 (0.55) KDM4EGABRG2GABRB3GABRA1GABRA2
SCHEMBL3394038 0.65 ALOX15 (0.44) KDM4EMAPTMAPK1KMT2ACYP1A2
SCHEMBL3395404 0.63 KCNH2 (0.47) MAPK1CYP1A2CYP2C19CDK1CHEK1
SCHEMBL13425543 0.62 NR1H4 (0.37) MAPK1KMT2ACYP1A2CYP2C19KDR
SCHEMBL11630169 0.61 HPGD (0.42) KDM4ETRPA1CYP2C19MARK3GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed